Reference
Ruck T, et al. T-cell mediated secondary autoimmunity following alemtuzumab treatment: 2 cases of vitiligo. Multiple Sclerosis Journal 24 (Suppl.): 711-712 (plus poster) abstr. P1248, No. 2, Oct 2018. Available from: URL: http://doi.org/10.1177/1352458518798591 [abstract] - Germany
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1776, 34 (2019). https://doi.org/10.1007/s40278-019-70192-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-70192-1